NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 372
Auteur Titel [ Jaar(Asc)]
2019
Verbrugge CAG, T. Hollander den, Stollenga M, Dijkstra BAG.  2019.  Hoofdstuk 28 Herstelsteun in de verslavingszorg, wat ga je er zelf aan doen? Handboek Steunend Relationeel Handelen.
van Noorden MS, Dijkstra BAG.  2019.  Hoofdstuk 5 GHB. Farmacotherapie bij verslaving.
Vink J, Schellekens AFA.  2019.  Hoofdstuk 7 Genetica van verslaving. Handboek Verslaving.
Jokubonis D, Adomaitiene V, Leleikiene A, Baltaityte L, Dirzius E, De Jong CAJ.  2019.  How to integrate addiction medicine in psychiatry training: results of an experiment with two educational methods. Open Review of Educational Research. 6(1)
van Rijswijk SM, van Beek MHCT, Schoof GM, Schene AH, Steegers M, Schellekens AFA.  2019.  Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review. Gen Hosp Psychiatry. 59:37-50.
Klaassen R., van Delden R., VanDerNagel JEL, Kamp M., Thio B., Heylen D..  2019.  In body experiences: Persuasion by doing. CEUR workshop proceedings. 2340
Bruijnen CJWH, Jansen M, Dijkstra BAG, Walvoort SJW, Lugtmeijer S, Markus W, de Jong CAJ, Kessels RPC.  2019.  The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: A validation study for clinical practice. Journal of Substance Use. 24(1)
Schellekens AFA, Vanderschuren L.  2019.  Neurobiologie van verslaving. Handboek Verslaving.
Van de Wijer L, Garcia LP, Hanswijk SI, Rando J, Middelman A, Heine RTer, de Mast Q, Martens GJM, Van der Ven AJAM, Kolk SM et al..  2019.  Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model. Transl Psychiatry. 9(1):84.
Van de Wijer L, Mchaile DN, de Mast Q, Mmbaga BT, Rommelse NNJ, Duinmaijer A, Van der Ven AJAM, Schellekens AFA, Kinabo GD.  2019.  Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study. Lancet HIV. 6(4):e250-e258.
Ebenau A, Dijkstra BAG, Huurne CTer, Hasselaar J, Vissers K, Groot M.  2019.  Palliative care for people with substance use disorder and multiple problems: a qualitative study on experiences of patients and proxies. BMC Palliat Care. 18(1):56.
Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Markus W, VanDerNagel JEL, Kessels RPC, DeJong CAJ.  2019.  Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev. 38(4):435-442.
Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Markus W, VanDerNagel JEL, Kessels RPC, de Jong CAJ.  2019.  Prevalence of cognitive impairment in patients with substance use disorder. The Authors Drug and Alcohol Review .
Beurmanjer H, Asperslag EM, Oliemeulen L, Goudriaan AE, De Jong CAJ, Schellekens AFA, Dijkstra BAG.  2019.  A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.. Eur Addict Res. 25(5):248-255.
Bruijnen CJWH, Young SY, Marx M, Seedat S.  2019.  Social anxiety disorder and childhood trauma in the context of anxiety (behavioural inhibition), impulsivity (behavioural activation) and quality of life. South African Journal of Psychiatry. 25:1-7.
van Lier HG, Pieterse ME, Garde A, Postel MG, de Haan H.A., Vollenbroek-Hutten MMR, Schraagen JMaarten, Noordzij ML.  2019.  A standardized validity assessment protocol for physiological signals from wearable technology: Methodological underpinnings and an application to the E4 biosensor. Behav Res Methods.
VanDerNagel JEL, van Duijvenbode N, Didden R.  2019.  Substance use disorders. Handbook of intellectual disabilities – Integrating theory, research, and practice.
van Duijvenbode N, VanDerNagel JEL.  2019.  A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability. Eur Addict Res. :1-20.
van Esch AMJ, Fest A, Hoffland BS, Janzing JGE, Steens SCA, Esselink RAJ, Schellekens AFA.  2019.  Toxic Leukoencephalopathy Presenting as Lethal Catatonia. J Addict Med. 13(3):241-244.

Pagina's